About one-third of patients adhere to subcutaneous immunotherapy regardless of cost

Only about one-third of patients adhered to their course of maintenance doses in their subcutaneous immunotherapy even when there were no out-of-pocket expenses, according to a study published in Annals of Allergy, Asthma & Immunology.
The combined retrospective and prospective observational electronic medical record review examined subcutaneous immunotherapy (SCIT) at a military treatment facility (MTF) in San Antonio between 2005 and 2012, Jun Mendoza, MD, allergist-immunologist, 10th Medical Group Allergy Clinic, U.S. Air Force Academy, and colleagues wrote.
Annual premiums for care at

Only about one-third of patients adhered to their course of maintenance doses in their subcutaneous immunotherapy even when there were no out-of-pocket expenses, according to a study published in Annals of Allergy, Asthma & Immunology.
The combined retrospective and prospective observational electronic medical record review examined subcutaneous immunotherapy (SCIT) at a military treatment facility (MTF) in San Antonio between 2005 and 2012, Jun Mendoza, MD, allergist-immunologist, 10th Medical Group Allergy Clinic, U.S. Air Force Academy, and colleagues wrote.
Annual premiums for care at